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Background: The combined use of Robot-assisted UL training and Botulinum toxin
(BoNT) appear to be a promising therapeutic synergism to improve UL function in chronic
stroke patients.
Objective: To evaluate the effects of Robot-assisted UL training on UL spasticity,
function, muscle strength and the electromyographic UL muscles activity in chronic
stroke patients treated with Botulinum toxin.
Methods: This single-blind, randomized, controlled trial involved 32 chronic stroke
outpatients with UL spastic hemiparesis. The experimental group (n = 16) received
robot-assisted UL training and BoNT treatment. The control group (n = 16) received
conventional treatment combined with BoNT treatment. Training protocols lasted for 5
weeks (45 min/session, two sessions/week). Before and after rehabilitation, a blinded
rater evaluated patients. The primary outcome was the Modified Ashworth Scale (MAS).
Secondary outcomes were the Fugl-Meyer Assessment Scale (FMA) and the Medical
Research Council Scale (MRC). The electromyographic activity of 5 UL muscles during
the “hand-to-mouth” task was explored only in the experimental group and 14 healthy
age-matched controls using a surface Electromyography (EMGs).
Results: No significant between-group differences on the MAS and FMA were
measured. The experimental group reported significantly greater improvements on UL
muscle strength (p= 0.004; Cohen’s d= 0.49), shoulder abduction (p= 0.039; Cohen’s
d= 0.42), external rotation (p= 0.019; Cohen’s d= 0.72), and elbow flexion (p= 0.043;
Cohen’s d = 1.15) than the control group. Preliminary observation of muscular activity
showed a different enhancement of the biceps brachii activation after the robot-assisted
training.
Gandolfi et al. Robot-Assisted Training for Upper Limb Spasticity
Conclusions: Robot-assisted training is as effective as conventional training on muscle
tone reduction when combined with Botulinum toxin in chronic stroke patients with
UL spasticity. However, only the robot-assisted UL training contributed to improving
muscle strength. The single-group analysis and the qualitative inspection of sEMG
data performed in the experimental group showed improvement in the agonist muscles
activity during the hand-to-mouth task.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT03590314
Keywords: upper limb, rehabilitation, robotics, electromyography, spasticity
INTRODUCTION
Upper limb (UL) sensorimotor impairments are one of the major
determinants of long-term disability in stroke survivors (1).
Several disturbances are the manifestation of UL impairments
after stroke (i.e., muscle weakness, changes in muscle tone, joint
disturbances, impaired motor control). However, spasticity and
weakness are the primary reason for rehabilitative intervention
in the chronic stages (1–3). Historically, spasticity refers to
a velocity-dependent increase in tonic stretch reflexes with
exaggerated tendon jerks resulting from hyperexcitability of the
stretch reflex (4) while weakness is the loss of the ability to
generate the normal amount of force.
From 7 to 38% of post-stroke patients complain of UL
spasticity in the first year (5). The pathophysiology of spasticity
is complicated, and new knowledge has progressively challenged
this definition. Processes involving central and peripheral
mechanisms contribute to the spastic movement disorder
resulting in abnormal regulation of tonic stretch reflex and
increased muscle resistance of the passively stretched muscle
and deficits in agonist and antagonist coactivation (6, 7).
The resulting immobilization of the muscle at a fixed length
for a prolonged time induces secondary biomechanical and
viscoelastic properties changes in muscles and soft tissues, and
pain (8–11). These peripheral mechanisms, in turn, leads to
further stiffness, and viscoelastic muscle changes (2, 8). Whether
the muscular properties changes may be adaptive and secondary
to paresis are uncertain. However, the management of UL
spasticity should combine treatment of both the neurogenic and
peripheral components of spasticity (9, 10).
UL weakness after stroke is prevalent in both acute and
chronic phases of recovery (3). It is a determinant of UL function
in ADLs and other negative consequences such as bone mineral
content (3), atrophy and altered muscle pattern of activation.
Literature supports UL strengthening training effectiveness for all
levels of impairment and in all stages of recovery (3). However, a
small number of trials have been performed in chronic subgroup
patients, and there is still controversy in including this procedure
in UL rehabilitation (3).
Botulinum toxin (BoNT) injection in carefully selected
muscles is a valuable treatment for spastic muscles in
stroke patients improving deficits in agonist and antagonist
coactivation, facilitating agonist recruitment and increasing
active range of motion (6–8, 12–14). However, improvements
in UL activity or performance is modest (13). With a view
of improving UL function after stroke, moderate to high-
quality evidence support combining BoNT treatment with other
rehabilitation procedures (1, 9, 15). Specifically, the integration
of robotics in the UL rehabilitation holds promise for developing
high-intensity, repetitive, task-specific, interactive treatment of
upper limb (15). The combined use of these procedures to
compensate for their limitations has been studied in only one
pilot RCT reporting positive results in UL function (Fugl-Meyer
UL Assessment scale) and muscular activation pattern (16). With
the limits of the small sample, the results support the value of
combining high-intensity UL training by robotics and BoNT
treatment in patients with UL spastic paresis.
Clinical scales are currently used to assess the rehabilitation
treatment effects, but these outcome measures may suffer
from some drawbacks that can be overcome by instrumental
assessment as subjectivity, limited sensitivity, and the lack of
information on the underlying training effects on motor control
(17). Instrumental assessment, such as surface electromyography
(sEMG) during a functional task execution allows assessing
abnormal activation of spastic muscles and deficits of voluntary
movements in patients with stroke.
Moreover, the hand-to-mouth task is representative of
Activities of Daily Life (ADL) such as eating and drinking.
Kinematic analysis of the hand-to-mouth task has been
widely used to assess UL functions in individuals affected by
neurological diseases showing adequate to more than adequate
test-retest reliability in healthy subjects (18, 19). The task involves
flexing the elbow a slightly flexing the shoulder against gravity,
and it is considered to be a paradigmatic functional task for
the assessment of spasticity and strength deficits on the elbow
muscles (17, 20). Although sEMGhas been reported to be a useful
assessment procedure to detect muscle activity improvement
after rehabilitation, limited results have been reported (16, 21).
The primary aim of this study was to explore the therapeutic
synergisms of combined robot-assisted upper limb training and
BoNT treatment on upper limb spasticity. The secondary aimwas
to evaluate the treatment effects on UL function, muscle strength,
and the electromyographic activity of UL muscles during a
functional task.
The combined treatment would contribute to decrease UL
spasticity and improve function through a combination of
training effects between BoNT neurolysis and the robotic
treatment. A reduction of muscle tone would parallel
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improvement in muscle strength ought to the high-intensity,
repetitive and task-specific robotic training. Since spasticity is
associated with abnormal activation of shortening muscles and
deficits in voluntary movement of the UL, the sEMG assessment
would target these impairments (2, 8–11, 15).
MATERIALS AND METHODS
Trial Design
A single-blind RCT with two parallel group is reported. The
primary endpoint was the changes in UL spasticity while the
secondary endpoints were changes in UL function, muscle
strength and the electromyographic activity of UL muscles
during a functional task. The study was conducted according to
the tenets of the Declaration of Helsinki, the guidelines for Good
Clinical Practice, and the Consolidated Standards of Reporting
Trials (CONSORT), approved by the local Ethics Committee
“Nucleo ricerca clinica–Research and Biostatistic Support Unit”
(prog n.2366), and registered at clinical trial (NCT03590314).
Patients
Chronic post-stroke patients with upper-limb spasticity referred
to the Neurorehabilitation Unit (AOUI Verona) and the
Physical Medicine and Rehabilitation Section, “OORR” Hospital
(University of Foggia) were assessed for eligibility.
Inclusion criteria were: age > 18 years, diagnosis of
ischemic or hemorrhagic first-ever stroke as documented by a
computerized tomography scan or magnetic resonance imaging,
at least 6 months since stroke, Modified Ashworth Scale (MAS)
score (shoulder and elbow) ≤3 and ≥1+ (22), BoNT injection
within the previous 12 weeks of at least one of muscles of the
affected upper limb, Mini-Mental State Examination (MMSE)
score ≥24 (23) and Trunk Control Test score= 100/100 (24).
Exclusion criteria were: any rehabilitation intervention in the
3 months before recruitment, bilateral cerebrovascular lesion,
severe neuropsychologic impairment (global aphasia, severe
attention deficit or neglect), joint orthopedic disorders.
All participants were informed regarding the experimental
nature of the study. Informed consent was obtained from all
subjects. The local ethics committee approved the study.
Interventions
Each patient underwent a BoNT injection in the paretic limb.
The dose of BoNT injected into the target muscle was based
on the severity of spasticity in each case. Different commercial
formulations of BoNTwere used according to the pharmaceutical
portfolio contracts of our Hospitals (Onabotulinumtoxin A,
Abobotulinumtoxin A, and Incobotulinumtoxin A). The dose,
volume and number of injection sites were set accordingly. A
Logiq R© Book XP portable ultrasound system (GE Healthcare;
Chalfont St. Giles, UK) was used to inject BoNT into the target
muscle.
Before the start of the study authors designed the
experimental (EG) and the control group (CG) protocols.
Two physiotherapists, one for each group, carried out the
rehabilitation procedures. Patients of both groups received
ten individual sessions (45 min/session, two sessions/week,
five consecutive weeks). Treatments were performed in the
rehabilitative gym of the G. B. Rossi University Hospital
Neurological Rehabilitation Unit, or “OORR” Hospital.
Robot-Assisted UL Training
The Robot-assisted UL Training group was treated using the
electromechanical device Armotion (Reha Technology, Olten,
Switzerland). It is an end-effector device that allows goal-directed
arm movements in a bi-dimensional space with visual feedback.
It offers different training modalities such as passive, active,
passive-active, perturbative, and assistive modes. The robot
can move, drive or oppose the patient’s movement and allows
creating a personalized treatment, varying parameters such as
some repetitions, execution speed, resistance degree of motion.
The exercises available from the software are supported by games
that facilitate the functional use of the paretic arm (25). The robot
is equipped with a control system called “impedance control”
that modulates the robot movements for adapting to the motor
behavior of the patient’s upper limb. The joints involved in the
exercises were the shoulder and the elbow, is the wrist fixed to
the device.
The Robot-assisted UL Training consisted of passive
mobilization and stretching exercises for affected UL (10min)
followed by robot-assisted exercises (35min). Four types of
exercises contained within the Armotion software and amount
of repetitions were selected as follows: (i) “Collect the coins”
(45–75 coins/10min), (ii) “Drive the car” (15–25 laps/10min),
(iii) “Wash the dishes” (40–60 repetitions/10min), and (iv)
“Burst the balloons” (100–150 balloons/5min) (Figure 1). All
exercises were oriented to achieving several goals in various
directions, emphasizing the elbow flexion-extension and
reaching movement. The robot allows participants to execute
the exercises through an “assisted as needed” control strategy.
For increment the difficulty, we have varied the assisted and
FIGURE 1 | The upper limb robot-assisted training setting.
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non-assisted modality, increasing the number of repetitions over
the study period.
Conventional Training
The conventional training consisted of UL passive mobilization
and stretching (10min) followed by UL exercises (35min) that
incorporated single or multi-joint movements for the scapula,
shoulder, and elbow, performed in different positions (i.e., supine
and standing position). The increase of difficulty and progression
of intensity were obtained by increasing ROM, repetitions and
performing movements against gravity or slight resistance (26).
Training parameters were recorded on the patient’s log.
Outcomes
Clinical and demographic data were collected at enrollment.
The primary outcome was the changes on the UL MAS score
computed as the sum of evaluation of shoulder, elbow, and
wrist muscles (single-joint score range, 0–4; with higher scores
indicating worse spasticity; total score, 0–12; with higher scores
indicating worse spasticity) (16).
Secondary outcomes included changes on the Fugl Meyer
Upper Limb Assessment scale (FMA) (27) (score range, 0–66;
with higher scores indicating better performance), a widely used
measure of UL function composed by 33 items assessing reflex
activity, muscle strength, and movement control. Moreover,
changes on the UL muscle strength were assessed by the Medical
Research Council Scale (MRC) computed as the sum of the
score from shoulder flexion/abduction/external rotation, elbow
flexion/extension and wrist supination/flexion/extension (single-
movement score range, 0–5; with higher scores indicating muscle
strength against full resistance; total score, 0–40; with higher
scores indicating muscle strength against full resistance) (28, 29).
Patients were assessed by a blinded rater before (T0) and post-
treatment (T1). A subgroup of patients in the experimental group
was investigated by surface Electromyography (EMGs) during
the “hand-to-mouth” motor task (ARAT sub-item).
EMG Protocol
The subject seated in a comfortable position on a chair with
a backrest, the feet resting on the floor and the knees and
hips flexed at 90◦. The start position consisted of the hand
of the examined side lying on the distal third of the thigh.
Then, the patient was asked to touch his mouth with the
palm at average speed and return to the starting position.
The patient was instructed not to move the head toward the
hand. No other indications regarding how to move the arm
for not to influence the spontaneity of the movement. The
EMG activity of 5 upper limb muscles of the affected side
(deltoid scapular, deltoid clavicular, pectoralis major–clavicular
head, triceps brachii, biceps brachii) was measured using pairs of
self-adhesive surface electrodes. Disposable Ag-AgCl electrodes
were placed according to SENIAM guidelines with an inter-
electrode spacing of 0.02m. Before electrode placement, the
skin was shaved with a disposable, single-use razor and cleaned
with alcohol (30). Raw EMG signals were collected using BTS
FREEEMG 300 wireless surface EMG sensors (BTS spa, Milan,
Italy) at a sampling rate of 1,000Hz. Raw EMG signals were
processed with a customized routine developed in MATLAB
environment (MathWorks, USA). The raw EMG signal was
bandpass filtered at 20–450Hz and then smoothed using a 20-
ms root mean square (RMS) algorithm to obtain the envelope.
Signals were recorded in three conditions: 30 s during resting
position (basal), 5 s of maximal voluntary isometric contraction
(MVIC), and during the hand-to-mouth task. The hand-to-
mouth task has been widely used to assess UL functions in
individuals affected by neurological diseases showing adequate
to more than adequate test-retest reliability in healthy subjects
(18, 19).
The task was divided into two sub-phases through the
definition of three time-events: (1) start of the movement, (2)
the moment when the hand touches the mouth, and (3) return
to the initial position. The first sub-phase, named “elbow flexion
phase,” was defined as the interval between the movement onset
and the maximum elbow flexion. The second sub-phase, named
“return phase,” refers to the interval between themaximum elbow
flexion until movement offset after returning to the starting
position. Normative data were collected from 14 healthy age-
matched controls undergoing one EMGs acquisition. The time-
events were determined using an accelerometer (BTS spa, Milan,
Italy).
Sample Size
Sample calculation took into account that in a similar study
by Pennati et al. a difference in the MAS total score of 2.75
was detected between the experimental and the control group
(pooled SD 2.77) because of the experimental rehabilitation (16).
According to this study, a sample of at least 28 patients (14
per group) was estimated to have 80% power and an alpha
(probability of type I error) of 5%. Assuming a 10% drop-out rate,
31 patients were necessary to perform the study.
Randomization
The patients considered eligible were randomly assigned to the
experimental group or control group (allocation ratio 1:1) by
using a computer-generated random numbers list with simple
randomization (www.randomization.org). Group allocation and
the randomization list was kept concealed.
Blinding
The same blinded examiner measured primary and secondary
outcomes at each evaluation session. Another blinded assessor
performed the EMG protocol.
Statistical Analysis
An intention to treat analysis was used. Descriptive statistics
included means, standard deviation and graph. The Shapiro-
Wilk test was used to test data distribution. Parametric or non-
parametric tests were used for inferential statistics, accordingly.
The T-Test for unpaired data (or the Mann-Whitney test)
was used for testing between-group differences at T0 and T1.
For this purpose, we computed the changes of the score (1)
between T0–T1. The T-Test for paired data (or Wilcoxon signed
rank tests) was used to compare within-group changes over
time. The effects size measures between the two independent
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groups (Cohen’s d calculation) were used to evaluate the
magnitude of the between-group treatment effects. The Pearson
correlation test was performed for testing the association between
FMA and MRC scores. The EMG signals were processed by
using an adaptive pre-whitening filter and the approximated
generalized likelihood-ratio (AGLR) algorithm to detect the
muscle activity. The onset and offset of muscle activity were
analyzed as the percentage of the movement cycle. A qualitative
analysis of sEMG graphic records was carried out. Training
efficiency was calculated as the number of repetitions divided
by the number of minutes of active therapy (31). The level
of significance was set p < 0.05. Software statistics SPSS 20.0
(IBM SPSS Statistics for Windows, Version 20.0, Armonk, NY,
USA).
RESULTS
Forty nine patients were evaluated for eligibility between
February 2017 and April 2018. Twelve patients were
excluded because they did not meet the inclusion criteria
and five declined to participate. Thus, 32 patients were
randomly allocated to the EG (n = 16) or CG (n = 16).
All patients complete the study (Figure 2 and Table 1).
A mean training efficiency of 7.3 repetitions/min and
2.2 repetitions/min was computed in the EG and CG,
respectively. Matching in initial between-group conditions
TABLE 1 | Demographic and clinical characteristics of treated subjects.
Experimental
group
Control
group
Between-group
comparison
(n = 16) (n = 16)
Age (years)
Mean (SD)
Range
59.31 (14.40)
21–77
59.13 (14.97)
21–78
n.s.
Gender (%)
Male/Female
12/4 10/6 n.s.
Disease duration since
diagnosis (years)
Mean (SD)
6.0 (3.1) 5.1 (2.2) n.s.
Side of paresis (%)
Right/Left
62.5/37.5 50/50 n.s.
Modified Barthel Index
Mean (SD)
Range
68.75 (19.87)
35–95
68.13 (16)
35–95
n.s.
SD, standard deviation; n.s, not significant.
FIGURE 2 | Flow diagram of the study.
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no significant differences as to age, disease duration,
and all baseline clinical measures at T0 were measured
(Tables 1, 2).
Primary Outcome Measure
Both groups reduced UL spasticity significantly without
reporting significant between-group differences (Table 2).
Secondary Outcome Measures
Both groups improved UL function significantly without
significant between-group differences (Table 2). The
experimental group reported significantly greater improvements
on UL muscle strength (delta T1–T0 = 3.62, p = 0.004, Cohen’s
d = −0.49), shoulder abduction (delta T1–T0 = 0.62, p = 0.039,
Cohen’s d = −0.42), external rotation (delta T1–T0 = 0.53, p =
0.019, Cohen’s d=−0.72) and elbow flexion (delta T1–T0=0.59,
p = 0.043, Cohen’s d = −1.15) than the control group (Table 2).
Changes in UL muscle strength were significantly correlated
with changes in FMA (r = 0.49, p = 0.05). The results of sEMG
analysis are reported in Figures 3–5. The mean envelopes of
sEMG signals of the healthy subjects and patients of the EG are
shown as a function of the movement progression.
Based on the results, the mean sEMG envelope computed
on the healthy subjects’ recordings (Figure 3) shows a low but
constant recruitment of scapular deltoid and triceps brachii
during the entire movement. On the other hand, the activation
of the biceps brachii, clavicular deltoid, and pectoralis major
is higher during the first phase and decreases during the
second phase. It corresponds to the typical muscular recruitment
occurring during the execution of the required reaching
movement (32).
The samemean sEMG enveloped computed on stroke patients
at T0 (Figure 4, left) showed a similar trend, especially in the
first phase: during the second phase the decrease of the biceps
brachii, clavicular deltoid and pectoralis major is higher than that
observed in the healthy subjects.
At T1 (Figure 4, right) the time of sustained activation of
the biceps brachii is much longer if compared to the activation
observed at T0: in fact, the decrease which starts at about 70%
of the movement corresponds to a double value if compared to
T0 (∼0.06 vs. 0.03mV). In addition, the value observed in the
healthy subjects at the transition of the two phases is∼0.035mV,
the corresponding value observed in the subjects at T1 is ∼0.7
mV: this higher mean sEMG activation value corresponds to
a different abnormal recruitment pattern of this muscle in the
recruited patients.
As regards the analysis of the mean sEMG envelope of
single subjects, patient #1 at T0 (Figure 5 top left) shows a
poor modulation of recorded muscles which is more regular
at T1 (Figure 5 bottom left). The activation of patient #2 at
T0 is almost absent (Figure 5 top right), while at T1 (Figure 5
bottom right) the modulation of muscles is clear. In both
cases the plots at T1 highlight a change of the muscular
recruitment probably due to the proposed upper limb training
program.
DISCUSSION
The main finding of this work is that robot-assisted training is
as effective as conventional training on muscle tone reduction
when combined with Botulinum toxin in chronic stroke patients
with UL spasticity. However, only the robot-assisted UL training
contributed to improving muscle strength with a moderate
positive correlation with UL function. Preliminary observation
of muscular activity in the experimental group showed, in some
subjects, enhancement of the agonist muscles activity during
the hand-to-mouth task. It might suggest a task-specific effect
of the robot-assisted approach on muscle activity during the
functional task. However, the sEMG protocol was not focused
on investigating the relationship between abnormal activation of
agonists and antagonists’ muscles as it was limited to a qualitative
analysis of sEMG envelope.
The combined use of BoNT injection and robot-assisted
UL training appears to be a promising combination to target
the different sensorimotor impairments because spasticity is
associated with abnormal activation of shortening muscles and
deficits in the UL voluntary movements (2, 8–11, 15). On
the one hand, BoNT appears to be effective in the reduction
of the neural components of the spastic movement disorders
facilitating agonist recruitment and decreasing co-contraction of
the antagonist’s muscles. On the other hand, robotic devices can
reduce muscle tone and motor impairment (1).
Given the multiplicity of symptoms that often need to
be addressed in the UL rehabilitation of stroke patients, the
integration of robotics holds promise for developing high-
intensity, repetitive, task-specific, interactive treatment (15).
Despite significant heterogeneity in the robotic system design
(exoskeletons and end-effectors) and clinical research paradigms
used, a consensus exists on the safety and value of robot-
assisted UL therapy in reducing motor impairment, mainly at
the shoulder and elbow (15, 33). The effects of robot-assisted
therapy on muscle tone remains uncertain as only two reviews
have specifically addressed this topic (34).
A recent systematic meta-analysis in 38 trials evaluated the
effects of robot-assisted UL training in patients after a stroke
on outcomes of motor control of the paretic upper limb, upper
limb capacity, and basic ADL, in comparison with non-robotic
treatment. Secondary outcomes weremuscle strength andmuscle
tone. No serious adverse events were reported. Results reported
significant improvements in UL motor control (about 2 points
FMA UL sub-items) and muscle strength after robot-assisted
training. Shoulder/elbow robotics showed small but significant
effects on both motor control and muscle strength, while
elbow/wrist robotics had small but significant effects only on
motor control. Uncertain effects were reported for muscle tone
assessed by the Modified Ashworth Scale (34). No effects were
found for upper limb capacity and basic ADL. In the review
by Bertani and colleagues 14 randomized controlled trials, two
systematic reviews, and one meta-analysis were included (35).
The Fugl-Meyer and Modified Ashworth scale were selected
to measure primary outcomes, a measure of motor function
and muscle tone, respectively. Functional independence measure
and motor activity log were selected to measure secondary
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TABLE 2 | Clinical outcome measures and inferential statistics.
Mean
between-group
differences
Between groups comparison Mean within-group
differences
Within-groups
comparison
T0 T1 T1 T0 T1–T0 T1–T0 T1–T0
Outcome
Measure
Group Mean (SD)
Median [Q1; Q3]
Mean (SD)
Median [Q1; Q3]
Mean (LB; UB) 95%
CI
p P (ES) Mean (LB; UB)
95% CI
p
PRIMARY OUTCOME MEASURE
MASγ upper
limb
EG 3.75 [3.00; 6.62] 3.50 [2.00; 4.75] −0.12 (−1.48; 1.23) n.s n.s (−0.02) −1.18 (−2.10; −0.27) 0.008
CG 4.25 [3.25; 5.37] 3.00 [2.00; 5.50] −1.15 (−1.72; −0.59) 0.003
SECONDARY OUTCOME MEASURES
FMA EG 28.75 (11.92) 32.38 (11.84) 2.12 (−6.81; 11.06) n.s n.s (−0.17) 3.62 (1.77; 5.48) 0.001
CG 27.94 (10.82) 34.5 (12.89) 6.56 (3.75; 9.36) 0.001
MRC
Total UL EG 23.00 [14.37;
25.25]
24.75 [16.37;
27.37]
0.56 (−4.50; 5.63) n.s 0.004 (0.49) 3.62 (2.16; 5.08) 0.001
CG 23.00 [16.12;
28.37]
26.25 [17.75;
28.37]
0.90 (−0.31; 2.13) n.s.
Shoulder
flexionγ
EG 3.00 [2.00; 3.50] 3.00 [3.00; 4.00] 0.37 (−0.32; 1.07) n.s n.s. 0.40 (−0.14; 0.66) 0.01
CG 3.00 [3.00; 4.00] 4.00 [3.50; 4.00] 0.34 (0.13; 0.55) 0.009
Shoulder
abductionγ
EG 3.00 [2.00; 4.00] 3.25 [3.00; 4.00] 0.21 (−0.22; 0.65) n.s 0.039 (−0.42) 0.62 (0.25; 0.99) 0.007
CG 3.50 [3.00; 4.00] 3.50 [3.12; 4.00] 0.12 (−0.02; 0.27) n.s.
Shoulder’s
external
rotationγ
EG 2.00 [2.00; 3.00] 3.00 [2.00; 3.00] 0.00 (−0.80; 0.80) n.s 0.019 (−0.72) 0.53 (0.26; 0.79) 0.004
CG 3.00 [2.00; 3.00] 3.00 [3.00; 3.37] −0.06 (−0.43; 0.31) n.s.
Elbow
flexionγ
EG 3.00 [2.00; 4.00] 4.00 [3.00; 4.00] −0.25 (−0.77; 0.27) n.s 0.043 (−1.15) 0.59 (0.16; 1.02) 0.008
CG 3.00 [3.00; 3.50] 3.00 [3.00; 3.50] 0.00 (−0.25; 0.25) n.s.
Elbow
extensionγ
EG 3.25 [2.00; 4.00] 4.00 [2.25; 4.00] 0.00 (−0.81; 0.81) n.s n.s. 0.53 (−0.11; 0.94) 0.017
CG 3.50 [3.00; 4.00] 3.50 [3.12; 4.00] 0.25 (0.03; 0.46) 0.038
Forearm’s
supinationγ
EG 2.50 [1.00; 3.00] 3.00 [1.00; 3.37] 0.25 (−0.89;1.39) n.s n.s. 0.40 (0.08; 0.73) 0.024
CG 3.00 [0.25; 4.00] 3.75 [1.00; 4.00] 0.21 (−0.05; 0.49) n.s.
Wrist flexionγ EG 2.00 [0.25; 3.37] 3.00 [1;00; 3.87] 0.12 (−0.90; 1.15) n.s n.s. 0.31 (−0.01; 0.63) n.s.
CG 3.00 [1.00; 3.87] 3.00 [1.00; 3.87] −0.03 (−0.33; 0.26) n.s.
Wrist
extensionγ
EG 2.00 [0.25; 3.00] 2.00 [1.25; 4.00] −0.15 (−1.20; 0.89) n.s n.s. 0.21 (−0.07; 0.51) n.s.
CG 2.50 [0.25; 3.37] 2.50 [1.00; 3.00] 0.06 (−0.33; 0.46) n.s.
γnon-parametric statistics.
P≤ 0.05.
FMA, Fugl Meyer Assessment; MAS, Modified Ashworth Scale; MRC, Medical Research Council; ES. Effect size; EG, Experimental Group; CG, Control Group; CI, Confidence Interval;
SD, Standard Deviation; Q1, 25◦ interquartile; Q3, 75◦ interquartile; LB, Lower Bound; UB, Upper Bound; n.s., not significant.
outcomes, such as activities of daily living. According to previous
findings, the robot-assisted UL rehabilitation was more effective
in improving upper limb motor function recovery, especially in
chronic stroke patients than conventional therapy. No significant
improvements were observed in the reduction of muscle tone or
daily living activities (35).
Few studies have explored the combined effects of
pharmacological treatments of UL spasticity and robot-assisted
rehabilitation, so far (16, 36, 37). These preliminary results agree
that greater improvements from the combined approach are
expected in UL function, as assessed by the FMA. However, the
training effects on spasticity and UL use in the ADL have found
disagreement between the different studies (16, 36, 37).
With the limits of methodological differences among studies,
the present study corroborates some elements of the existing
literature (16). Some equivalence between the robot-assisted and
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FIGURE 3 | EMGs muscle activity during the “hand-to-mouth” task in healthy controls.
FIGURE 4 | EMGs muscle activity during the “hand-to-mouth” task in stroke patients before and after the upper limb Robot-assisted training.
conventional approaches was noticed in UL function, while no
differences in the MAS were reported. Interestingly, the UL
robot-assisted training increased UL muscle strength in specific
muscles involved during functional tasks, outcome not included
in earlier studies (16, 37). Historically, strengthening training has
been a subject of controversy in stroke rehabilitation. However,
this procedure is now included in post-stroke rehabilitation
programs given the absence of adverse effects on spasticity and
the positive consequences reported on strength and activity (3,
38). Strength training is commonly considered to be progressive
resistance exercise. However, any intervention that involves
attempted repetitive effortful muscle contractions can result
in increased motor unit activity and increase strength (37).
Besides, exercising entailing more numerous repetitions but
with a reduced workload are recommended in post-stroke
patients (31). There is growing evidence suggesting the crucial
role of the treatment dose in functional recovery. However, a
lack of consensus on the quantification of training intensity
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FIGURE 5 | Lesions displayed on the magnetic resonance imaging brain template and electromyographic activity of the five upper limb muscles during the
“hand-to-mouth” task was explored using a surface Electromyography (EMGs) in two patients. (A) Top left: Lesion Mapping (patient 1). Magnetic resonance imaging
showed a lesion involving the left fronto-parietal lobes. Brodmann areas 48, 40, 39, 6, 44, 45, 3, 7, 22, 41, 2, 42, 4, 19, 43, 37, 21,47,9, 46, 1, 18, 23, 10 (MRIcron
software, http://www.mricro.com/mricron). The electromyographic activity of the 5 UL muscles during the “hand-to-mouth” task was explored using a surface
Electromyography (EMGs). (B) Top right: Lesion Mapping (patient 2). Magnetic resonance imaging showed a lesion involving the left frontal lobe. Brodmann areas 48,
45, 44, 6, 46, 43, 4, 3, 47, 32, 9, 38, 22, 10 (MRIcron software, http://www.mricro.com/mricron). The electromyographic activity of the 5 UL muscles during the
“hand-to-mouth” task was explored using a surface Electromyography (EMGs).
and its relationship with UL recovery patterns exists. Within
this perspective, the ratio between the number of repetitions
divided by the total time dedicated to the training has been
reported to be a useful parameter to quantify training intensity
and efficiency (31). These data could be relevant to evaluate
the cost-effectiveness of technology-mediated rehabilitation as
robot-assisted training. Robotics, in fact, allows implementing
high-standardized training in term of numbers of repetition
and progression of intensity and workload over time (15). The
knowledge of the underlying neuromuscular mechanisms is
of great interest in neurorehabilitation. With the limitations
of the single-group analysis and the qualitative inspection
of data, sEMG can reveal myographic activity reflecting the
physiological processes that occur following cortical damage and
changes promoted by rehabilitation training (39). The surface
EMG assessment in this perspective allowed to observe specific
impairments in proximal agonist muscle activity in the hand-to-
mouth task, as reported in Figure 4 and as an example in two
patients in Figure 5. Before treatment, the decrease of the biceps
brachii, clavicular deltoid, and pectoralis major was higher than
that observed in the healthy subjects suggesting an impairment
in the eccentric contraction of elbow flexors and modulation of
the internal shoulder rotator during the return (second) phase of
the task. Five distinctive UL spasticity patterns has been identified
for the position of the shoulder, elbow, forearm, and wrist joints
(39). The most frequent (41.8%) is characterized by internal
rotation and adduction of the shoulder and flexion at the elbow
coupled with a neutral positioning of the forearm and wrist
(40). The significance to recognize these patterns is essential to
guide specific pharmacological and rehabilitative interventions
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(7, 39). The instrumental assessment of these patterns during
UL movement using the sEMG analysis can reveal dynamic
pattern of altered activation during specific task phases to further
customize rehabilitation procedures. The results suggested that
Armotion could act selectively on these proximal muscles. At
the end of the treatment, the mean time of sustained activation
of the biceps brachii was much longer if compared to the
activation observed pre-treatment. The analysis of the mean
sEMG envelope of single subjects is an example of how the
robot-assisted training might improve the modulation of elbow
flexors muscles (Figure 4, top left) and increase their activation
(Figure 4 top right) during active task. Similarly, Pennati et al.
performed a qualitative analysis of sEMG graphic records during
two gestures: reaching the wall and return to the mouth and
reaching movement to a visual target (16). Their results showed
an improvement in muscle activation pattern and a reduction
of co-contraction of agonist-antagonist muscles after the robotic
exercises.
The strengths of the present study are the relatively large
patient sample and the low drop-out rate, which suggest
the feasibility of robotic training. The EMG analysis using a
standardized experimental protocol to investigate the training
effects on muscle activity are further strengths of this study,
albeit only in a subgroup of patients (experimental group).
The study limitations are the lack of a functional assessment
after the treatment, measurement on activities of daily living
and participation and patient related outcome. In addition,
any patient stratification by the degree of impairment, the
lack of follow-up assessment and neuroimaging support were
reported.
This preliminary study has implications for practice
and research. These findings suggest that UL robot-assisted
strengthening interventions combined with pharmacological
neurolysis increase strength and do not increase spasticity.
Thus, strengthening programs should be part of rehabilitation
after stroke to improve function and activity. Robot-assisted
rehabilitation offers a wide range of training modalities that
can be chosen for an individualized treatment in terms of
assistance (passive, active-assisted, active) and perturbation.
Research would be oriented toward ideal training models
(i.e., number of repetitions, progression, duration) and how
long the training effects last after the intervention. Surface
EMG should be part of this multidisciplinary intervention to
characterize specific pattern and to focus the training exercises to
specific muscle impairment. It could help researchers to design
studies with accurate patients’ selection and stratification with
specific impairments and similar likelihood of responding to
rehabilitation. It is essential to draw up recommendations for a
therapeutic guide of UL spasticity management in chronic stroke
patients with UL spasticity.
To conclude, upper limb robot-assisted training
holds promise when combined with botulinum toxin
in improving upper limb strength and muscular
activation pattern in patients with chronic stroke and
spasticity.
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